Pregabalin
Home / API - Commercial / Pregabalin
CAS No.
148553-50-8
Therapeutic Category
- Anti-convulsant
Innovator Brand
LYRICA
GMP
Available
DMF
Not Available
Filed
Under Filing
-
Sample
Available
Indication
Lyrica is indicated for:
Neuropathic pain associated with diabetic peripheral neuropathy (dpn) • postherpetic neuralgia (phn)
Adjunctive therapy for the treatment of partial onset seizures in patients 4 years of age and older
Fibromyalgia
Neuropathic pain associated with spinal cord injury
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.